Inhibrx Biosciences, Inc. Profile Avatar - Palmy Investing

Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate tar…

Biotechnology
US, La Jolla [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Inhibrx Biosciences, Inc. (INBX) to it's peer group.

Peer Group
Loading...
End of INBX's Analysis
CIK: 1739614 CUSIP: 45720L107 ISIN: US45720L1070 LEI: - UEI: -
Secondary Listings
INBX has no secondary listings inside our databases.